JUPITER NEUROSCIENCES, INC. (JUNS) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US48208B2034
JUPITER NEUROSCIENCES, INC. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 0.00 USD | 21,796.00 USD |
| Gross profit | – | 17,565.00 USD |
| Operating income | -3.09 m USD | -8.91 m USD |
| EBIT | -2.20 m USD | -8.58 m USD |
| Net income | -2.44 m USD | -8.64 m USD |
| Diluted EPS – continuing operations | -0.08 USD | -0.25 USD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About JUPITER NEUROSCIENCES, INC.
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and internationally. It operates in two segments, Pharmaceutical Operations and Premium Nutritional Supplements. The company researches and develops JNS115, which is in Phase IIa clinical trial for the treatment of Parkinson's disease; JNS108, which is in Phase II clinical trial for the treatment of mild cognitive impairment/early Alzheimer's disease; JNS102, which is in Phase II clinical trial for the treatment of mucopolysaccharidosis type 1; and JNS107, which is in Phase II clinical trial for the treatment of mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome. It is also involved in the commercialization and sale of GLO for skin beauty, MND for mental clarity, and PWR for energy, endurance, and muscle recovery under the Nugevia brand name. The company was formerly known as Jupiter Orphan Therapeutics, Inc. and changed its name to Jupiter Neurosciences, Inc. in August 2021. Jupiter Neurosciences, Inc. was incorporated in 2016 and is headquartered in Jupiter, Florida.
More stocks
- CANEX Metals Inc (CANX.V)
- Onano Industrial Corp (6405.TW)
- Genasys Inc. (GNSS)
- Sambo Motors Co. Ltd (053700.KQ)
- HeXun Biosciences Co., Ltd. (6986.TWO)
- Morefield Group N.V. (MORE.AS)
- Strong H Machinery Technology (Cayman) Incorporation (4560.TW)
- Gseven Co Ltd (2937.TWO)
- T&R Biofab Co. Ltd (246710.KQ)
- CHAMPIONS ONCOLOGY, INC. (CSBR)
- COGNITION THERAPEUTICS INC (CGTX)
- Integrated Solutions Technology, Inc. (6927.TWO)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.